These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 31870274)

  • 21. Predicting human genetic interactions from cancer genome evolution.
    Lu X; Megchelenbrink W; Notebaart RA; Huynen MA
    PLoS One; 2015; 10(5):e0125795. PubMed ID: 25933428
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Syn-lethality: an integrative knowledge base of synthetic lethality towards discovery of selective anticancer therapies.
    Li XJ; Mishra SK; Wu M; Zhang F; Zheng J
    Biomed Res Int; 2014; 2014():196034. PubMed ID: 24864230
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Graph regularized non-negative matrix factorization with [Formula: see text] norm regularization terms for drug-target interactions prediction.
    Zhang J; Xie M
    BMC Bioinformatics; 2023 Oct; 24(1):375. PubMed ID: 37789278
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Computational methods, databases and tools for synthetic lethality prediction.
    Wang J; Zhang Q; Han J; Zhao Y; Zhao C; Yan B; Dai C; Wu L; Wen Y; Zhang Y; Leng D; Wang Z; Yang X; He S; Bo X
    Brief Bioinform; 2022 May; 23(3):. PubMed ID: 35352098
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Link synthetic lethality to drug sensitivity of cancer cells.
    Wang R; Han Y; Zhao Z; Yang F; Chen T; Zhou W; Wang X; Qi L; Zhao W; Guo Z; Gu Y
    Brief Bioinform; 2019 Jul; 20(4):1295-1307. PubMed ID: 29300844
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CSSLdb: Discovery of cancer-specific synthetic lethal interactions based on machine learning and statistic inference.
    Dou Y; Ren Y; Zhao X; Jin J; Xiong S; Luo L; Xu X; Yang X; Yu J; Guo L; Liang T
    Comput Biol Med; 2024 Mar; 170():108066. PubMed ID: 38310806
    [TBL] [Abstract][Full Text] [Related]  

  • 27. NSF4SL: negative-sample-free contrastive learning for ranking synthetic lethal partner genes in human cancers.
    Wang S; Feng Y; Liu X; Liu Y; Wu M; Zheng J
    Bioinformatics; 2022 Sep; 38(Suppl_2):ii13-ii19. PubMed ID: 36124790
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A graph regularized generalized matrix factorization model for predicting links in biomedical bipartite networks.
    Zhang ZC; Zhang XF; Wu M; Ou-Yang L; Zhao XM; Li XL
    Bioinformatics; 2020 Jun; 36(11):3474-3481. PubMed ID: 32145009
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predicting cancer-specific vulnerability via data-driven detection of synthetic lethality.
    Jerby-Arnon L; Pfetzer N; Waldman YY; McGarry L; James D; Shanks E; Seashore-Ludlow B; Weinstock A; Geiger T; Clemons PA; Gottlieb E; Ruppin E
    Cell; 2014 Aug; 158(5):1199-1209. PubMed ID: 25171417
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Drug-Target Interaction Prediction via Dual Laplacian Graph Regularized Logistic Matrix Factorization.
    Wang A; Wang M
    Biomed Res Int; 2021; 2021():5599263. PubMed ID: 33855072
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ASTER: A Method to Predict Clinically Relevant Synthetic Lethal Genetic Interactions.
    Liany H; Jayagopal A; Huang D; Lim JQ; Nbh NI; Jeyasekharan A; Ong CK; Rajan V
    IEEE J Biomed Health Inform; 2024 Mar; 28(3):1785-1796. PubMed ID: 38227408
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Drug-Target Interaction Prediction with Graph Regularized Matrix Factorization.
    Ezzat A; Zhao P; Wu M; Li XL; Kwoh CK
    IEEE/ACM Trans Comput Biol Bioinform; 2017; 14(3):646-656. PubMed ID: 26890921
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protein functional properties prediction in sparsely-label PPI networks through regularized non-negative matrix factorization.
    Wu Q; Wang Z; Li C; Ye Y; Li Y; Sun N
    BMC Syst Biol; 2015; 9 Suppl 1(Suppl 1):S9. PubMed ID: 25708164
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SL-scan identifies synthetic lethal interactions in cancer using metabolic networks.
    Zangene E; Marashi SA; Montazeri H
    Sci Rep; 2023 Sep; 13(1):15763. PubMed ID: 37737478
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Systematic analysis of cancer-specific synthetic lethal interactions provides insight into personalized anticancer therapy.
    Guo L; Dou Y; Xiang Y; Luo L; Xu X; Wang Q; Zhang Y; Liang T
    FEBS J; 2023 Mar; 290(6):1531-1548. PubMed ID: 36181326
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthetic Lethality-based Identification of Targets for Anticancer Drugs in the Human Signaling Network.
    Liu L; Chen X; Hu C; Zhang D; Shao Z; Jin Q; Yang J; Xie H; Liu B; Hu M; Ke K
    Sci Rep; 2018 May; 8(1):8440. PubMed ID: 29855504
    [TBL] [Abstract][Full Text] [Related]  

  • 37. SL-BioDP: Multi-Cancer Interactive Tool for Prediction of Synthetic Lethality and Response to Cancer Treatment.
    Deng X; Das S; Valdez K; Camphausen K; Shankavaram U
    Cancers (Basel); 2019 Oct; 11(11):. PubMed ID: 31671773
    [TBL] [Abstract][Full Text] [Related]  

  • 38. WGRCMF: A Weighted Graph Regularized Collaborative Matrix Factorization Method for Predicting Novel LncRNA-Disease Associations.
    Liu JX; Cui Z; Gao YL; Kong XZ
    IEEE J Biomed Health Inform; 2021 Jan; 25(1):257-265. PubMed ID: 32287024
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multi-omics characterization of synthetic lethality-related molecular features: implications for SL-based therapeutic target screening.
    Weng S; Ruan H
    FEBS J; 2023 Mar; 290(6):1477-1480. PubMed ID: 36461713
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Graph Regularized Probabilistic Matrix Factorization for Drug-Drug Interactions Prediction.
    Jain S; Chouzenoux E; Kumar K; Majumdar A
    IEEE J Biomed Health Inform; 2023 May; 27(5):2565-2574. PubMed ID: 37027562
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.